View Scopus Profile

Susanne Arnold, MD

Professor, College of Medicine, Internal Medicine
Joint Appointment, College of Medicine, Radiation Medicine
Associate Director for Clinical Translation, TO Program Leader, Markey Cancer Center / Cancer Research Priority Initiative
Member, Translational Oncology Research Program, Markey Cancer Center / Cancer Research Priority Initiative
Buck-Kentucky Lung Cancer Research Chair, Markey Cancer Center / Cancer Research Priority Initiative

800 Rose Street
40536 Lexington
United States

h-index

Research activity per year

If you made any changes in Pure these will be visible here soon.

33 Active
125 Finished

150 - 158 out of 158 results

Finished

SWOG UCOP Urologic Cancer Outreach Program
Arnold, S. & Rowland, R.
Southwest Oncology Group
2/5/02 → 12/31/15
Project: Research project
Docetaxel, Carboplatin and Radiation Followed by Surgical Resection of Patients with State IIIA and B Non-Small Cell Lung Cancer
Arnold, S.
Aventis Pharmaceuticals Products Inc
8/1/01 → 4/30/04
Project: Research project
A Randomized, Double-Blind, Placebo-Controlled Phase II Study of CI-994 or Placebo in Combination withPaclitaxel and Carboplatin in First Line Treatment of Patients with Advanced Non-Small Cell Lung Cancer
Arnold, S.
Pfizer Inc.
7/1/01 → 6/30/06
Project: Research project
A Randomized Phase II/III Multicenter Trial of Docetaxel Plus Cisplatin and Docetaxel Plus 5-Fluorouracil Versus Cisplatin Plus 5-Fluorouracil in First Line Treatment
Arnold, S.
Aventis Pharmaceuticals Products Inc
6/1/01 → 10/31/02
Project: Research project
A Phase III Trial of ALIMTA vs Docetaxel in Patients with Locally Advanced or Metastasic Non-Small Lung Cancer (NSCLC) who were previously treated with Chemotherapy
Arnold, S.
Eli Lilly and Company
12/1/00 → 10/31/04
Project: Research project
Phase II Study of BBR 3464 as Treatment in Patients with Sensitive or Refractory Small Lung Cancer after one Prior Chemotherapy Regimen
Arnold, S.
Theradex
11/1/00 → 6/30/02
Project: Research project
A randomized, Double-Blind, Phase III Comparative Trial of Two Doses of ZD 1839 in Combination with Paclitaxel and Carboplatin Versus Placebo in Combination with Paclitaxel and Carboplatin in Chemotherapy Patient with Advanced Non-Small Cell Lung Cancer
Arnold, S.
AstraZeneca
10/1/00 → 9/30/04
Project: Research project
Paclitaxel., Carboplatin and Radiotherapy as Induction Therapy in Locally Advanced Head and Neck Cancer
Arnold, S.
Bristol Myers Squibb Company
9/1/00 → 1/31/03
Project: Research project

Your message has successfully been sent.

Your message was not sent due to an error.